(USA) Lyxor MSCI USA D-EUR - Ratings and Ratios
US Stocks, Equity Fund, Large Cap, Index Tracker
Description: USA Lyxor MSCI USA D-EUR
The Lyxor UCITS MSCI USA D-EUR (PA:USA) is an ETF that tracks the Morningstar US LM NR USD index, providing exposure to US large-cap blend equities. As a France-based ETF, it offers a diversified portfolio of US stocks, making it a suitable investment for those seeking to tap into the US equity market.
From a technical analysis perspective, the ETFs price is currently above its 20-day and 50-day simple moving averages (SMA20 and SMA50), indicating a short-term bullish trend. However, it is below its 200-day simple moving average (SMA200), suggesting a potential long-term bearish trend. The Average True Range (ATR) is 4.41, representing a 0.90% daily price volatility, which is relatively moderate. The ETFs 52-week high and low prices are 551.96 and 420.02, respectively, indicating a significant price range over the past year.
Key Performance Indicators (KPIs) for this ETF include its Assets Under Management (AUM), which stands at 3601.42M EUR, indicating a substantial investor base. Other relevant KPIs include the ETFs tracking error, which is not provided, but is essential in evaluating the funds ability to replicate the underlying index. Additionally, the ETFs expense ratio, trading volume, and bid-ask spread are crucial in assessing its cost-effectiveness and liquidity. Assuming an average expense ratio for a US large-cap ETF, this funds costs are likely to be competitive. However, a more detailed analysis of these KPIs is necessary to determine the ETFs overall performance and potential for future growth.
To further evaluate this ETF, it is essential to examine its underlying holdings, sector allocation, and historical performance. The MSCI USA index is a broad representation of the US equity market, with a mix of growth and value stocks across various sectors. By analyzing the ETFs sector allocation and stock holdings, investors can gain insights into its potential strengths and weaknesses. Moreover, reviewing the ETFs historical performance, including its returns over various timeframes and its risk-adjusted metrics, such as the Sharpe ratio, can help investors make a more informed decision.
Additional Sources for USA ETF
USA ETF Overview
Market Cap in USD | 4,249m |
Category | US Large-Cap Blend Equity |
TER | 0.21% |
IPO / Inception | 2014-07-04 |
USA ETF Ratings
Growth Rating | 64.0 |
Fundamental | - |
Dividend Rating | 37.2 |
Rel. Strength | -8.71 |
Analysts | - |
Fair Price Momentum | 475.43 EUR |
Fair Price DCF | - |
USA Dividends
Dividend Yield 12m | 1.10% |
Yield on Cost 5y | 2.08% |
Annual Growth 5y | 1.28% |
Payout Consistency | 84.7% |
Payout Ratio | % |
USA Growth Ratios
Growth Correlation 3m | 73.3% |
Growth Correlation 12m | 13.9% |
Growth Correlation 5y | 87.7% |
CAGR 5y | 14.04% |
CAGR/Max DD 5y | 0.59 |
Sharpe Ratio 12m | 0.48 |
Alpha | -8.93 |
Beta | 0.878 |
Volatility | 10.45% |
Current Volume | 0.2k |
Average Volume 20d | 0.2k |
As of July 04, 2025, the stock is trading at EUR 498.50 with a total of 192 shares traded.
Over the past week, the price has changed by +1.92%, over one month by +1.70%, over three months by +8.46% and over the past year by +4.82%.
Yes. Based on ValueRay's Analyses, Lyxor MSCI USA D-EUR (PA:USA) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 63.99 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of USA is around 475.43 EUR . This means that USA is currently overvalued and has a potential downside of -4.63%.
Lyxor MSCI USA D-EUR has no consensus analysts rating.
According to our own proprietary Forecast Model, USA Lyxor MSCI USA D-EUR will be worth about 553 in July 2026. The stock is currently trading at 498.50. This means that the stock has a potential upside of +10.94%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 553 | 10.9% |